Status:
ACTIVE_NOT_RECRUITING
Avenir Complete Post-Market Clinical Follow-Up Study
Lead Sponsor:
Zimmer Biomet
Conditions:
Osteoarthritis, Hip
Avascular Necrosis of Hip
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The main objectives of this study are to confirm the long-term safety, performance and clinical benefits the Avenir Complete femoral stem and its instrumentation when used in primary total, hemi, and ...
Detailed Description
The main objectives of this study are to confirm the long-term safety, performance and clinical benefits the Avenir Complete™ femoral stem and its instrumentation when used in primary total, hemi, and...
Eligibility Criteria
Inclusion
- Patient is at least 20 years old or older and skeletally mature.
- Advanced wear of the joint due to degenerative, post-traumatic or rheumatic diseases;
- Failed previous hip surgery including
- Joint reconstruction (osteotomy)
- Arthrodesis
- Hemi-arthroplasty or total hip replacement (THR)
- Acute traumatic fracture of the femoral head or neck;
- Avascular necrosis of the femoral head.
- Patients capable of understanding the surgeon's explanations and following his instructions, able and willing to participate in the follow-up program and who gave consent to take part in the study;
Exclusion
- Acute, chronic, local, or systemic infections;
- Severe muscular, neural, or vascular diseases that endanger the limbs involved;
- Lack of bony structures proximal or distal to the joint, so that good Inclusion criteria
- Patient is at least 20 years old or older and skeletally mature.
- Advanced wear of the joint due to degenerative, post-traumatic or rheumatic diseases;
- Failed previous hip surgery including
- Joint reconstruction (osteotomy)
- Arthrodesis
- Hemi-arthroplasty or total hip replacement (THR)
- Acute traumatic fracture of the femoral head or neck;
- Avascular necrosis of the femoral head.
- Patients capable of understanding the surgeon's explanations and following his instructions, able and willing to participate in the follow-up program and who gave consent to take part in the study;
- Exclusion criteria
- Acute, chronic, local, or systemic infections;
- Severe muscular, neural, or vascular diseases that endanger the limbs involved;
- Lack of bony structures proximal or distal to the joint, so that good anchorage of the implant is unlikely or impossible;
- Total or partial absence of the muscular or ligamentous apparatus;
- Any concomitant diseases that can jeopardize the functioning and the success of the implant;
- Allergy to the implanted material, especially to metal (e.g. cobalt, chromium, nickel, etc.);
- Local bone tumors and/or cysts;
- Pregnancy;
- Skeletal immaturity.
- Patients unwilling or unable to give consent, or to comply with the follow-up program;
- Patients who have any condition that would - in the judgement of the Investigator - place him/her at undue risk or
- interfere with the study;
- Any vulnerable subject:
- a prisoner
- mentally incompetent or unable to understand what participation in the study entails
- a known alcohol or drug abuser
- anticipated to be non-compliant
- Patients with plans to relocate during the study follow-up period;
- Individuals whose willingness to volunteer in a clinical investigation could be unduly influenced by the expectation, whether justified or not, of benefits associated with participation or of retaliatory response from senior members of a hierarchy in case of refusal to participate;
Key Trial Info
Start Date :
September 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2036
Estimated Enrollment :
275 Patients enrolled
Trial Details
Trial ID
NCT04731077
Start Date
September 27 2021
End Date
June 1 2036
Last Update
June 18 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Mississippi Sports Medicine and Orthopaedic Center PLLC
Jackson, Mississippi, United States, 39202
2
Heartland Regional Medical Center d.b.a. Mosaic Life Care
Saint Joseph, Missouri, United States, 64506
3
Orthopedic & Fracture Clinic, PC
Portland, Oregon, United States, 97225
4
Copenhagen University Hospital, Hvidovre
Copenhagen, Denmark, DK-2650